State of the Art: 2063 (for Shadowrun)
Published by FanPro
Written by Rob Boyle, Elissa Carey, Drew Curtis, Eleanor Holmes, Jamie Houston, Robyn King-Nitschke, Michelle Lyons, Peter Millholland, Jon Szeto
Art by John Bridgegroom, Marko Djurdjevic, Steve Prescott, Marc Sasso, Klaus Schwerinski, Jason Vargas
208 B&W softcover; $19.99
Most Shadowrun supplements tend to revolve around a certain theme, like magic, cyberware, megacorps, and so on. State of the Art: 2063 is different; instead of having a single, unifying topic, it is presented as a quick overview over the hottest topics in the World of 2063.
As it is the norm for all Shadowrun supplement except for the "core books" (such as Magic in the Shadows or Man and Machine), each chapter is presented as a file posted to the Shadowland Data Haven, with various attached comments by the shadowrunner community. Since there is no way of knowing which, if any, of these comments are ultimately "true" in the game world, the GM can pick and choose which are true, and which are only unfounded rumors or corporate disinformation. Any relevant game rule information can be found at the end of each chapter.
The first chapter deals with genetic engineering, and its applications as of 2063. There is enough discussion of the basics of these technology, the megacorps involved, and the specific difficulties and possibilities involved with genetically engineering awakened species to allow GMs to create shadowruns . . .
This article originally appeared in the second volume of Pyramid. See the current Pyramid website for more information.
Article publication date: October 4, 2002
Copyright © 2002 by Steve Jackson Games. All rights reserved. Pyramid subscribers are permitted to read this article online, or download it and print out a single hardcopy for personal use. Copying this text to any other online system or BBS, or making more than one hardcopy, is strictly prohibited. So please don't. And if you encounter copies of this article elsewhere on the web, please report it to email@example.com.